![Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression](https://becarispublishing.com/cms/10.2217/cer-2020-0276/asset/ef240e5c-3183-4e9a-8312-8cd435feace3/assets/images/large/figure2.jpg)
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression
![Full article: Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States Full article: Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States](https://www.tandfonline.com/cms/asset/fb441971-1f11-4aad-8fb7-17088b5cb884/ijme_a_2208993_f0002_c.jpg)
Full article: Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States
![Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai's PCN-101 Phase 2a Readout - Psychedelic Alpha Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai's PCN-101 Phase 2a Readout - Psychedelic Alpha](http://psychedelicalpha.com/wp-content/uploads/2022/11/Spravato-pricing-1.png)
Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai's PCN-101 Phase 2a Readout - Psychedelic Alpha
![Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services](https://ps.psychiatryonline.org/cms/10.1176/appi.ps.201900625/asset/images/medium/appi.ps.201900625f1.gif)
Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services
![Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services](https://ps.psychiatryonline.org/cms/10.1176/ps.2020.71.issue-10/asset/174e3082-0717-e308-a071-4e3082a07174/ps.2020.71.issue-10.cover.jpg)
Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services
![SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder](https://d1l0gza1nowsqe.cloudfront.net/wp-content/uploads/sites/4/2022/05/Spravato6001PPS0_620.jpg)
SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
![US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior](https://becarispublishing.com/cms/10.2217/cer-2021-0226/asset/450a6d84-3f76-4672-921e-81896add8c42/assets/images/large/figure1.jpg)
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior
![Find Esketamine Nasal Spray spravato by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App Find Esketamine Nasal Spray spravato by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App](https://production-uploads-cdn.anar.biz/uploads/image/image/9068560/medium_6d25f851-e22e-4451-866e-1005dbe5a7b6_1655934306203_photo.webp)
Find Esketamine Nasal Spray spravato by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App
![Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha](https://psychedelicalpha.com/wp-content/uploads/2022/12/New-Spravato-Data-1-1024x576.png)
Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha
![Frontiers | Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study Frontiers | Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study](https://www.frontiersin.org/files/Articles/1250987/fpsyt-14-1250987-HTML-r4/image_m/fpsyt-14-1250987-g001.jpg)
Frontiers | Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study
![ATUc programme timelines for esketamine in France. ANSM, the French... | Download Scientific Diagram ATUc programme timelines for esketamine in France. ANSM, the French... | Download Scientific Diagram](https://www.researchgate.net/publication/358690671/figure/fig1/AS:11431281097389958@1668561515836/ATUc-programme-timelines-for-esketamine-in-France-ANSM-the-French-National-Agency-for.jpg)
ATUc programme timelines for esketamine in France. ANSM, the French... | Download Scientific Diagram
![Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates - ScienceDirect Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165032722010898-gr1.jpg)
Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates - ScienceDirect
![SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News](https://hospitalprofessionalnews.ie/wp-content/uploads/2022/03/spravato-esketamine-spray-233x300-1.png)